Also listed on Sonoma Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 22, 2027 · High confidence
20-year base term ends Jan 22, 2027
Jan 22, 2007
Jan 22, 2027
Oct 10, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 22, 2007, when application 11/656,087, the earliest non-provisional in its chain, was filed (this one was filed Jul 7, 2015) | Jan 22, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,072,726, US 9,168,318) | resolves to Jan 22, 2027, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 22, 2027 | High confidence |
This family
| Application 11/656,087 | Abandoned not computed | not computed |
| US 9,072,726 | In force Jan 2027 | Jan 2027 |
| US 9,782,434 | this patent Jan 2027 | Jan 2027 |
| Application 15/729,138 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 5, 2017 Reel 41257, frame 375 | Oculus Innovative Sciences, Inc. | Sonoma Pharmaceuticals, Inc. | Change of Name |
| Sep 8, 2017 Reel 43530, frame 554 | Alimi, Hojabr; Gutierrez, Andres | Oculus Innovative Sciences, Inc. | Assignment of Assignor's Interest |
| Oct 14, 2020 Reel 54084, frame 495 | Sonoma Pharmaceuticals, Inc. | Microsafe Group DMCC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,072,726, US 9,168,318, ends no earlier than this term, so it caps nothing.